We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Biosensing Technology Breakthrough Paves Way for New Methods of Early Disease Detection

By LabMedica International staff writers
Posted on 11 Dec 2024

Nanopores are tiny openings that can detect individual molecules as they pass through, making them ideal for analyzing biomolecules like DNA and proteins. More...

However, detecting proteins at extremely low concentrations—such as those found in the early stages of diseases—has been challenging. Now, a new breakthrough in nanotechnology for biomolecule detection and analysis could open doors to more effective early disease detection methods.

In a study conducted at SMU Lyle (Dallas, TX, USA) and featured on the cover of Analytical Chemistry, researchers combined octahedral DNA origami structures with solid-state nanopores to enhance the detection of proteins, particularly those present in low concentrations. The researchers found that integrating DNA origami's precision with the strength of solid-state nanopores results in a "hybrid nanopore" system, offering more accurate and sensitive protein detection. DNA origami is a technique in which DNA strands are folded into specific shapes, such as an octahedron, to improve the nanopore’s capacity to capture and detect proteins. In their study, the researchers used holo human serum transferrin as a model protein, demonstrating that this hybrid nanopore system outperformed traditional nanopores in both sensitivity and detection accuracy.

Many diseases, including cancer and neurodegenerative disorders, are marked by proteins present in very small quantities, making them difficult to detect in the early stages. The hybrid nanopore's ability to detect these low-abundance proteins could lead to earlier diagnoses and more effective treatment outcomes. Moving forward, the research team plans to refine the DNA origami structure and nanopore configurations to further improve sensitivity and expand the range of detectable biomolecules. This innovative approach could revolutionize fields like drug discovery, disease diagnostics, and fundamental biological research.

“This work could pave the way for developing advanced biosensing technologies, with potential applications in biomedical research and diagnostic tools – especially for diseases marked by low-abundance protein biomarkers,” said SMU Lyle mechanical engineering graduate student Kamruzzaman Joty.


Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Collection and Transport System
PurSafe Plus®
Capillary Blood Collection Tube
IMPROMINI M3
New
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.